https://scientific-jl.com/luch/
Часть-42_ Том-2_ Апрель-2025
193
THE EFFECT OF ACETYL-L-CARNITINE ON DIABETIC
NEUROPATHY
Yakubova N.A. Dotsent Tashkent Medical Academy
Berdimurodov B.P. assistant Tashkent Medical Academy
Pardayeva M.N. assistant Tashkent Medical Academy
SHaxmurova M.A. assistant Tashkent Medical Academy
Key words: Diabetic neuropathy, Acetyl-L-carnitine, Mitochondrial, Neurology.
Introduction
Diabetic neuropathy (DN) is a chronic and debilitating complication that affects a
significant proportion of individuals with diabetes. It arises from prolonged
hyperglycemia, leading to nerve damage, particularly in the peripheral nervous
system. Symptoms of diabetic neuropathy, including pain, numbness, tingling, and
muscle weakness, significantly impair the quality of life of affected individuals.
Currently, no definitive cure for diabetic neuropathy exists, and existing therapies
primarily aim to manage symptoms, alleviate pain, and slow disease progression.
Among potential therapeutic agents for diabetic neuropathy, Acetyl-L-carnitine
(ALC) has garnered attention due to its neuroprotective, antioxidant, and
mitochondrial-enhancing properties. This literature review aims to synthesize the
existing evidence on the efficacy and mechanisms of action of ALC in the treatment
of diabetic neuropathy.
Acetyl-L-Carnitine: Mechanisms of Action
Acetyl-L-carnitine is an ester of L-carnitine, a naturally occurring compound
involved in fatty acid metabolism and mitochondrial function. In addition to its role
in energy production, ALC is known for its antioxidant and neuroprotective
properties, both of which are crucial in managing diabetic neuropathy. The
https://scientific-jl.com/luch/
Часть-42_ Том-2_ Апрель-2025
194
following mechanisms have been proposed to explain the therapeutic potential of
ALC in diabetic neuropathy:
1.
Antioxidant Effects:
Oxidative stress is a key factor in the pathophysiology of diabetic neuropathy,
where excess reactive oxygen species (ROS) contribute to nerve damage. ALC’s
antioxidant properties help mitigate oxidative damage by scavenging ROS and
enhancing the activity of endogenous antioxidant enzymes (1). This reduces the
cellular damage that accelerates neuropathy in diabetic patients.
2.
Improvement in Mitochondrial Function:
The mitochondria, the energy-producing organelles in cells, are vital for
фmaintaining nerve function. In diabetic neuropathy, mitochondrial dysfunction
contributes to nerve degeneration. ALC facilitates the transport of fatty acids into
mitochondria, improving energy production, which is essential for nerve repair and
function (2). This enhanced mitochondrial function is crucial for the regeneration
of damaged neurons.
3.
Neuroprotection and Nerve Regeneration:
ALC has been shown to promote the synthesis of acetylcholine, a
neurotransmitter that plays a key role in nerve signaling and repair. Additionally,
it supports the regeneration of myelin, the protective sheath surrounding nerves,
which is often damaged in diabetic neuropathy (3). This neuroprotective effect
helps preserve nerve function and slow the progression of neuropathy.
4.
Anti-inflammatory Effects:
Inflammation contributes to the development and progression of diabetic
neuropathy. ALC has demonstrated anti-inflammatory effects by inhibiting the
release of pro-inflammatory cytokines, thus reducing inflammation in nerve tissues
(4). This helps alleviate pain and prevent further damage to the nervous system.
https://scientific-jl.com/luch/
Часть-42_ Том-2_ Апрель-2025
195
Clinical Evidence of ALC in Diabetic Neuropathy
Several clinical studies have examined the effects of Acetyl-L-carnitine on
diabetic neuropathy, showing promising results in terms of symptom relief and
nerve function improvement. Below is a review of key studies that highlight the
efficacy of ALC in treating diabetic neuropathy:
1.
Pain Reduction:
A randomized controlled trial published in the
Journal of Clinical Neurology
demonstrated that ALC supplementation significantly reduced neuropathic pain in
patients with diabetic neuropathy (5). Participants receiving ALC reported
decreased pain intensity, providing evidence for ALC’s analgesic effects in
managing one of the most distressing symptoms of diabetic neuropathy.
2.
Improvement in Nerve Conduction Velocity:
A study published in
Diabetes Care
investigated the effects of ALC on nerve
conduction velocity (NCV), a key indicator of nerve function. Results showed that
ALC supplementation significantly improved NCV in diabetic neuropathy patients,
suggesting that ALC may help restore nerve function and prevent further
deterioration (6). Nerve conduction velocity is commonly reduced in individuals
with neuropathy, and improvements in NCV are indicative of functional nerve
repair.
3.
Quality of Life:
In addition to its effects on pain and nerve conduction, ALC has been shown to
improve overall quality of life in individuals with diabetic neuropathy. Clinical
trials have reported improvements in sensory and motor function, allowing patients
to regain mobility and independence (7). This is particularly important for
individuals whose neuropathy severely impacts daily activities.
4.
Neuroprotective Effects in Animal Models:
Preclinical studies in animal models of diabetic neuropathy have provided
further insight into the neuroprotective effects of ALC. These studies have shown
https://scientific-jl.com/luch/
Часть-42_ Том-2_ Апрель-2025
196
that ALC can protect sensory and motor neurons from degeneration induced by
hyperglycemia (8). By enhancing mitochondrial function and reducing oxidative
stress, ALC helps preserve nerve integrity and supports regeneration in animal
models, indicating potential benefits for humans.
Safety and Side Effects
Acetyl-L-carnitine is generally well-tolerated when used in appropriate doses.
Most clinical studies report few and mild side effects, which may include
gastrointestinal disturbances such as nausea, stomach upset, or diarrhea (9). In rare
cases, patients may experience headaches, insomnia, or mood changes. Overall,
ALC has a favorable safety profile, and no significant adverse effects have been
observed in long-term use. However, it is crucial for individuals with diabetes to
consult healthcare professionals before starting ALC supplementation, particularly
if they are on other medications. ALC has a low potential for interaction with
commonly prescribed drugs for diabetes, but personalized medical advice is
recommended.
Discussion
The existing literature provides strong evidence for the beneficial effects of
Acetyl-L-carnitine in managing diabetic neuropathy. Its ability to reduce pain,
improve nerve conduction, and promote nerve regeneration through antioxidant,
mitochondrial, and anti-inflammatory mechanisms makes it a promising adjunctive
therapy for diabetic neuropathy. However, further large-scale, long-term clinical
trials are necessary to establish optimal dosing regimens, evaluate long-term
efficacy, and determine the most suitable patient populations for treatment.
While ALC has demonstrated clear benefits in improving symptoms and quality of
life, it should be considered as part of a comprehensive treatment plan that includes
strict blood sugar control, lifestyle modifications, and other pharmacological
interventions.
https://scientific-jl.com/luch/
Часть-42_ Том-2_ Апрель-2025
197
Conclusion
Acetyl-L-carnitine represents a promising therapeutic option for individuals
suffering from diabetic neuropathy. Its multifaceted mechanisms of action,
combined with a favorable safety profile, position it as a valuable addition to the
treatment landscape for diabetic neuropathy. Ongoing research and clinical trials
will provide further insight into the full potential of ALC in managing this
debilitating condition.
References:
1.
Ruggieri, M. (2015). The role of oxidative stress in diabetic neuropathy.
Diabetes Research and Clinical Practice, 107
(1), 1-10.
2.
Lee, J., & Kim, H. (2016). Acetyl-L-carnitine enhances mitochondrial
function and reduces oxidative stress.
Journal of Clinical Endocrinology,
101
(5), 3189-3196.
3.
Gaballa, A., & Meade, J. (2017). Neuroprotective effects of acetyl-L-
carnitine in diabetic neuropathy.
Clinical Therapeutics, 39
(4), 763-770.
4.
Hwang, J., & Ryu, J. (2018). Anti-inflammatory effects of acetyl-L-carnitine
in diabetic neuropathy.
Journal of Diabetes & Metabolism, 45
(9), 1234-
1242.
5.
Kadir, S., & Seif, M. (2017). Efficacy of Acetyl-L-carnitine in reducing pain
in diabetic neuropathy: A clinical trial.
Journal of Clinical Neurology, 6
(4),
103-107.
6.
Huang, Q., et al. (2018). The effect of acetyl-L-carnitine on nerve conduction
velocity in diabetic patients.
Diabetes Care, 41
(3), 504-510.
7.
Johnson, S., & Ahmed, A. (2019). Quality of life improvement with acetyl-
L-carnitine in patients with diabetic neuropathy.
Diabetes Therapy, 10
(3),
815-822.
8.
Xu, Z., et al. (2016). Neuroprotective effects of acetyl-L-carnitine in
experimental diabetic neuropathy.
Neuropharmacology, 102
, 1-10.
9.
Zhang, L., et al. (2019). Safety and tolerability of acetyl-L-carnitine in the
management of diabetic neuropathy.
Journal of Clinical Pharmacology,
59
(7), 902-909.
